Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network-Reference-Cited by-同舟云学术

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network

Published:2022-06-11 Issue:9 Volume:57 Page:1458-1460
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Perovic Vladimir^ORCID,Sabol Ivan^ORCID,Grce Magdalena^ORCID,Inngjerdingen Marit,Pulanic Drazen,Peric Zinaida^ORCID,Peczynski Christophe^ORCID,Polge Emmanuelle,Koenecke Christian^ORCID,Dickinson Anne,Greinix Hildegard,Basak Grzegorz,Penack Olaf^ORCID,Scherwath Angela,Barata Anna^ORCID,Olivieri Attilio,Lawitschka Anita^ORCID,Mensah-Glanowska Patrycja^ORCID,Andrikovics Hajnalka,Schoemans Helene^ORCID,Wolff Daniel

Funder

European Cooperation in Science & Technology under the COST Action 17138

European Cooperation in Science and Technology (COST), COST Action 17138

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-022-01733-3.pdf

Reference9 articles.

1. Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, et al. The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transpl. 2019;54:1575–85. https://doi.org/10.1038/s41409-019-0465-9.

2. Lee SJ, Wolff D, Kitko C, Koreth J, Inamoto Y, Jagasia M, et al. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report. Biol Blood Marrow Transpl. 2015;21:984–99. https://doi.org/10.1016/j.bbmt.2015.02.025.